The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors

Diabetes and obesity are growing problems worldwide and are associated with a range of acute and chronic complications, including acute myocardial infarction (AMI) and stroke. Novel anti-diabetic medications designed to treat T2DM, such as glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sod...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Meiyuan, Wen, Song, Zhou, Ligang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417299/
https://www.ncbi.nlm.nih.gov/pubmed/36035518
http://dx.doi.org/10.2147/DMSO.S375559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417299/
https://www.ncbi.nlm.nih.gov/pubmed/36035518
http://dx.doi.org/10.2147/DMSO.S375559

Ejemplares similares